Vantage Consulting Group Inc

Investment Portfolio & 13F Holdings Analysis

About

Vantage Consulting Group Inc is an institutional investment manager that filed its latest Form 13F for 2025Q1, reporting 4 holdings worth $0.0 billion. Form 13F filings provide transparency into the equity holdings of institutional investment managers with over $100 million in assets under management. This page displays the most recent portfolio holdings, allowing investors to track position changes, new investments, and portfolio composition.

Filing Details

13F-HR • 2025-03-31

SEC FilingSEC DataHachi Filing

Report Date: 2025-03-31
Filing Date: 2025-05-09
Total Holdings: 4
Total Value: 5024027
Accession Number: 0001843547-25-000007
Form Type: 13F-HR
CIK: 0001843547
Manager Name: Vantage Consulting Group Inc

Data Enrichment

100% identified

4 identified0 unidentified

Holdings

SEC FilingSEC DataHachi Filing

Manager:

4 positions • $5,024.027K total value

4 positions

Manager:

SEC FilingSEC DataHachi Filing

Search and click to pin securities to the top

Sort by:

Cibus, Inc.

CBUS|17166A101

1143949(+0.0%)

Value:

$2.1B(-32.7%)

Babcock & Wilcox Enterprises, Inc.

BW|05614L209

2416200(+0.0%)

Value:

$1.6B(-59.0%)

ADC Therapeutics SA

ADCT|H0036K147

850737(+0.0%)

Value:

$1.2B(-29.1%)

FIBROGEN INC

FGEN|31572Q808

195707(+0.0%)

Value:

$60.6M(-41.5%)

Instrument	Shares		Other Manager	Value
Cibus, Inc.(CBUScusip17166A101)	1.1M	QoQ 0.00% (-0) YoY 0.00% (-0)	All Managers (Combined)	$2.1M	QoQ -32.73% (-$1.0M) YoY -91.67% (-$23.6M)
Babcock & Wilcox Enterprises, Inc.(BWcusip05614L209)	2.4M	QoQ 0.00% (-0) YoY 0.00% (-0)	All Managers (Combined)	$1.6M	QoQ -58.99% (-$2.3M) YoY -40.49% (-$1.1M)
Adc Therapeutics Sa(ADCTcusipH0036K147)	850.7K	QoQ 0.00% (-0) YoY 0.00% (-0)	All Managers (Combined)	$1.2M	QoQ -29.14% (-$493.4K) YoY -68.59% (-$2.6M)
Fibrogen Inc(FGENcusip31572Q808)	195.7K	QoQ 0.00% (-0) YoY 0.00% (-0)	All Managers (Combined)	$60.6K	QoQ -41.47% (-$43.0K) YoY -86.81% (-$399.3K)